๐ต๏ธ VYNE Therapeutics Inc. ($VYNE)
SEC insider & ownership activity, last 12 months ยท CIK 1566044 ยท every row links its SEC filing
Insiders were quiet over the last 12 months โ no open-market buys or sells. No red-flag 8-Ks in the window.
Insider flow
0 buyers, $0 (0 lots) ยท 0 sellers, $0 (0 lots)
No open-market insider transactions in the last 12 months.
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Logos Global Management LP | 10.7% | 13G | Aug 7, 2026 | filing โ | |
| Logos Global Management GP LLC | 10.7% | 13G | Aug 7, 2026 | filing โ | |
| Arsani William | 10.7% | 13G | Aug 7, 2026 | filing โ | |
| Janus Henderson Group Ltd. | 10.0% | 13G | Aug 7, 2026 | filing โ | |
| Perceptive Advisors LLC | 10.0% | 13G | Aug 3, 2026 | filing โ | |
| Joseph Edelman | 10.0% | 13G | Aug 3, 2026 | filing โ | |
| Perceptive Life Sciences Master Fund, Ltd. | 10.0% | 13G | Aug 3, 2026 | filing โ | |
| RTW Fund Group GP, LLC | 10.0% | 13G | Jul 30, 2026 | filing โ | |
| Roderick Wong | 10.0% | 13G | Jul 30, 2026 | filing โ | |
| venBio Global Strategic Fund V, L.P. | 10.0% | 13G | Aug 14, 2026 | filing โ | |
| venBio Global Strategic GP V, LLC | 10.0% | 13G | Aug 14, 2026 | filing โ | |
| Orbimed Advisors LLC | 10.0% | 13D | Jul 27, 2026 | filing โ | |
| ADAR1 Capital Management, LLC | 8.8% | 13G | Aug 14, 2026 | filing โ | |
| Daniel Schneeberger | 8.8% | 13G | Aug 14, 2026 | filing โ | |
| OrbiMed Capital GP X LLC | 8.7% | 13D | Jul 27, 2026 | filing โ | |
| OrbiMed Capital GP X, LP | 8.7% | 13D | Jul 27, 2026 | filing โ | |
| Logos Global Master Fund LP | 6.6% | 13G | Aug 7, 2026 | filing โ | |
| Logos GP LLC | 6.6% | 13G | Aug 7, 2026 | filing โ | |
| Access Industries Holdings LLC | 6.0% | 13D | Jul 27, 2026 | filing โ | |
| Access Industries Management, LLC | 6.0% | 13D | Jul 27, 2026 | filing โ | |
| Len Blavatnik | 6.0% | 13D | Jul 27, 2026 | filing โ | |
| AI Biotechnology LLC | 6.0% | 13D | Jul 27, 2026 | filing โ | |
| Nantahala Capital Management, LLC | 6.0% | 13G | May 15, 2026 | filing โ | |
| Wilmot B. Harkey | 6.0% | 13G | May 15, 2026 | filing โ | |
| Daniel Mack | 6.0% | 13G | May 15, 2026 | filing โ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Sep 10, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Sep 10, 2026 | filing โ |
| Other events (8.01) | Sep 10, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Sep 10, 2026 | filing โ |
| Other events (8.01) | Jul 29, 2026 | filing โ |
| Earnings (2.02) | Jul 24, 2026 | filing โ |
| Reg FD disclosure (7.01) | Jul 24, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jul 24, 2026 | filing โ |
| Material agreement (1.01) | Jul 24, 2026 | filing โ |
| Acquisition or disposition (2.01) | Jul 24, 2026 | filing โ |
| Earnings (2.02) | Jul 24, 2026 | filing โ |
| Unregistered equity sale (3.02) | Jul 24, 2026 | filing โ |
| Material Modifications to Rights of Security Holders (3.03) | Jul 24, 2026 | filing โ |
| Change of control (5.01) | Jul 24, 2026 | filing โ |
| Officer/director changes (5.02) | Jul 24, 2026 | filing โ |
| Charter/bylaw changes (5.03) | Jul 24, 2026 | filing โ |
| Amendments to the Registrant's Code of Ethics (5.05) | Jul 24, 2026 | filing โ |
| Reg FD disclosure (7.01) | Jul 24, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jul 24, 2026 | filing โ |
| Reg FD disclosure (7.01) | Jul 21, 2026 | filing โ |
| Other events (8.01) | Jul 21, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jul 21, 2026 | filing โ |
| Shareholder vote (5.07) | Jul 16, 2026 | filing โ |
| Reg FD disclosure (7.01) | Jul 14, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jul 14, 2026 | filing โ |
| Reg FD disclosure (7.01) | Jul 10, 2026 | filing โ |
| Other events (8.01) | Jul 10, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | Jul 10, 2026 | filing โ |
| Reg FD disclosure (7.01) | May 21, 2026 | filing โ |
| Financial Statements and Exhibits (9.01) | May 21, 2026 | filing โ |